Third Rock Ventures — 2014 Investments
3 investments dated 2014 · listed companies and verified rows first · show all
Clinical-stage biotechnology company developing conditionally activated, masked biologics designed to be localized to the tumor microenvironment.
BiotechSouth San Francisco, US
Sean McCarthy(Executive Officer, Director)
BoardTim Shannon(Director)inElaine V. Jones(Director)Frederick W. Gluck(Director)Hoyoung Huh(Director)
Board seatNeil Exter· per SEC Form D · $30M raise · filed Jan 2015
Co-investorsLongitude CapitalCanaan Partners
South San Francisco, US
John Schembri(Executive Officer)Ted W. Love(Executive Officer, Director)
BoardCharles Homcy, M.D.(Director)
Board seatKevin Starr· per SEC Form D
Co-investorsRA Capital
BiotechMt. Arlington, US
Paul Chaney(Executive Officer, Director)Kevin Starr(Director)Lutz Giebel(Director)Colin Goddard(Director)
BoardDavid Guyer(Director)
Board seatAbbie Celniker· per SEC Form D · $47.3M raise · filed Apr 2019
Co-investorsAstellas Venture Management LLCAgent Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.